Temat: "Neoplastic Stem Cells" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Revealing role of epigenetic modifiers and DNA oxidation in cell-autonomous regulation of Cancer stem cells.
Autorzy:: Ferrer-Diaz AI; Department of Medicine - Division of Hematology/Oncology, Rutgers, New Jersey Medical School, Newark, NJ, 07103, USA.; Rutgers School of Graduate Studies at New Jersey Medical School, Newark, NJ, USA.
Sinha G; Department of Medicine - Division of Hematology/Oncology, Rutgers, New Jersey Medical School, Newark, NJ, 07103, USA.; Rutgers School of Graduate Studies at New Jersey Medical School, Newark, NJ, USA.
Petryna A; Department of Medicine - Division of Hematology/Oncology, Rutgers, New Jersey Medical School, Newark, NJ, 07103, USA.; Rutgers School of Graduate Studies at New Jersey Medical School, Newark, NJ, USA.
Gonzalez-Bermejo R; University of Puerto Rico, Cayey, PR, Puerto Rico.
Kenfack Y; Department of Medicine - Division of Hematology/Oncology, Rutgers, New Jersey Medical School, Newark, NJ, 07103, USA.; Rutgers School of Graduate Studies at New Jersey Medical School, Newark, NJ, USA.
Adetayo O; Rutgers School of Dental Medicine, Newark, NJ, USA.
Patel SA; Division of Hematology and Oncology, Department of Medicine, UMass Memorial Medical Center, UMass Chan Medical School, Worcester, MA, USA.
Hooda-Nehra A; Department of Medicine - Division of Hematology/Oncology, Rutgers, New Jersey Medical School, Newark, NJ, 07103, USA.; Rutgers Cancer Institute of New Jersey, Newark, NJ, USA.
Rameshwar P; Department of Medicine - Division of Hematology/Oncology, Rutgers, New Jersey Medical School, Newark, NJ, 07103, USA. .; Pokaż więcej
Źródło:: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Feb 12; Vol. 22 (1), pp. 119. Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Neoplastic Stem Cells*/pathology
Neoplasms*/pathology
Humans ; Histones/genetics ; Epigenesis, Genetic ; Methyltransferases/genetics ; DNA ; Intracellular Signaling Peptides and Proteins/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation.
Autorzy:: Xue M; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.; Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Dong L; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.; Quantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, TX, 7539, USA.
Zhang H; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Li Y; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.; Department of Radiation Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, Guangdong, China.
Qiu K; Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA.
Zhao Z; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.; Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
Gao M; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Han L; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.; School of Pharmacy, China Medical University, Shenyang, 110001, Liaoning, China.
Chan AKN; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Li W; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Leung K; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Wang K; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Pokharel SP; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Qing Y; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Liu W; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Wang X; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Ren L; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Bi H; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Yang L; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Shen C; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Chen Z; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Melstrom L; Division of Surgical Oncology, Department of Surgery, Beckman Research Institute of City of Hope Comprehensive Cancer Center, Duarte, CA, 91010, USA.
Li H; Department of Molecular Medicine, City of Hope National Medical Center, Duarte, CA, 91016, USA.
Timchenko N; Division of General and Thoracic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Deng X; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.
Huang W; Department of Diabetes Complications and Metabolism, Diabetes and Metabolism Research Institute, Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA.; Graduate School of Biological Science, City of Hope, Duarte, CA, 91010, USA.
Rosen ST; City of Hope Comprehensive Cancer Center, City of Hope, Duarte, CA, 91010, USA.
Tian J; State Key Laboratory of Medical Genomics, Clinical Trial Center, Shanghai Institute of Endocrine and Metabolic Diseases, Department of Endocrinology and Metabolism, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Xu L; Quantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, TX, 7539, USA.
Diao J; Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, USA.
Chen CW; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.; City of Hope Comprehensive Cancer Center, City of Hope, Duarte, CA, 91010, USA.
Chen J; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA.; City of Hope Comprehensive Cancer Center, City of Hope, Duarte, CA, 91010, USA.; Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, 91010, USA.
Shen B; Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. .
Chen H; Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. .
Su R; Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, 91016, USA. .; City of Hope Comprehensive Cancer Center, City of Hope, Duarte, CA, 91010, USA. .; Pokaż więcej
Źródło:: Journal of hematology & oncology [J Hematol Oncol] 2024 Feb 01; Vol. 17 (1), pp. 7. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:: Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/genetics
Liver Neoplasms*/pathology
Neoplastic Stem Cells*/pathology
Animals ; Humans ; Mice ; Cell Line, Tumor ; Cell Self Renewal/genetics ; Methyltransferases/genetics ; Methyltransferases/metabolism ; Protein Biosynthesis ; Ribosomes/metabolism ; RNA

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: A positive feedback between PDIA3P1 and OCT4 promotes the cancer stem cell properties of esophageal squamous cell carcinoma.
Autorzy:: Huang T; Department of Thoracic Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China.
You Q; Department of Thoracic Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China.
Huang D; Department of Thoracic Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China.
Zhang Y; Department of Thoracic Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China.
He Z; Department of Thoracic Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China.
Shen X; Department of Thoracic Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China.
Li F; Department of Thoracic Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China.
Shen Q; Department of Thoracic Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China.
Onyebuchi IC; Department of Thoracic Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China.
Wu C; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China.
Liu F; Department of Thoracic Surgery, Lishui Branch, Zhongda Hospital Affiliated to Southeast University, Nanjing, 211200, China. .
Zhu S; Department of Thoracic Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, 241001, China. .; Pokaż więcej
Źródło:: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Jan 22; Vol. 22 (1), pp. 60. Date of Electronic Publication: 2024 Jan 22.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Esophageal Neoplasms*/genetics
Esophageal Squamous Cell Carcinoma*/genetics
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Octamer Transcription Factor-3*/genetics
Octamer Transcription Factor-3*/metabolism
Neoplastic Stem Cells*/metabolism
Humans ; RNA ; Ubiquitin-Protein Ligases ; Receptors, Nerve Growth Factor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Downregulation of TAB182 promotes cancer stem-like cell properties and therapeutic resistance in triple-negative breast cancer cells.
Autorzy:: He H; Department of Radiation Toxicology and Oncology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China.; NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, 130021, People's Republic of China.
Wang S; Department of Radiation Toxicology and Oncology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China.
Zhang W; Department of Radiation Toxicology and Oncology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China.
Gao S; Department of Radiation Toxicology and Oncology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China.
Guan H; Department of Radiation Toxicology and Oncology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China. .
Zhou P; Department of Radiation Toxicology and Oncology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Nov 13; Vol. 23 (1), pp. 1101. Date of Electronic Publication: 2023 Nov 13.
Typ publikacji:: Journal Article
MeSH Terms:: Neoplastic Stem Cells*/metabolism
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/metabolism
Telomeric Repeat Binding Protein 1*/genetics
Humans ; Cell Line, Tumor ; Cell Proliferation ; Down-Regulation ; Drug Resistance, Neoplasm/genetics ; Gene Expression Regulation, Neoplastic ; Signal Transduction

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: LINC00909 up-regulates pluripotency factors and promotes cancer stemness and metastasis in pancreatic ductal adenocarcinoma by targeting SMAD4.
Autorzy:: Li Z; Department of General Surgery, Heyuan people's Hospital, Heyuan, 517000, China.; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; Junior Clinical Cooperation Unit Translational Gastrointestinal Oncology and Preclinical Models, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
Ma Z; Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100730, China.
Wang S; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, 510515, China.
Yan Q; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; South China University of Technology School of Medicine, Guangzhou, Guangdong Province, 510006, China.
Zhuang H; Department of Hepatobiliary Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510080, China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510080, China.
Zhou Z; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; South China University of Technology School of Medicine, Guangzhou, Guangdong Province, 510006, China.
Liu C; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, 510515, China.
Chen Y; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; South China University of Technology School of Medicine, Guangzhou, Guangdong Province, 510006, China.
Han M; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, 510515, China.
Wu Z; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, 510515, China.
Huang S; Department of General Surgery, Heyuan people's Hospital, Heyuan, 517000, China.; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, 510515, China.; South China University of Technology School of Medicine, Guangzhou, Guangdong Province, 510006, China.
Zhou Q; Department of General Surgery, Hui Ya Hospital of The First Affiliated Hospital, Sun Yat-sen University, Huizhou, Guangdong, 516081, China. .; Department of Liver Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, China. .
Hou B; Department of General Surgery, Heyuan people's Hospital, Heyuan, 517000, China. .; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China. .; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, 510515, China. .; South China University of Technology School of Medicine, Guangzhou, Guangdong Province, 510006, China. .
Zhang C; Department of General Surgery, Heyuan people's Hospital, Heyuan, 517000, China. .; Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China. .; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, 510515, China. .; South China University of Technology School of Medicine, Guangzhou, Guangdong Province, 510006, China. .; Pokaż więcej
Źródło:: Biology direct [Biol Direct] 2024 Mar 19; Vol. 19 (1), pp. 24. Date of Electronic Publication: 2024 Mar 19.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Pancreatic Ductal*/genetics
Carcinoma, Pancreatic Ductal*/metabolism
Carcinoma, Pancreatic Ductal*/pathology
Pancreatic Neoplasms*/genetics
Animals ; Humans ; Mice ; Carcinogenesis/genetics ; Cell Line, Tumor ; Neoplastic Stem Cells/metabolism ; Neoplastic Stem Cells/pathology ; Phenotype ; Smad4 Protein/genetics ; Smad4 Protein/metabolism ; RNA, Untranslated/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Downregulation of circ-Foxo3 in breast cancer stem-like cells.
Autorzy:: Kamalabadi-Farahani M; Department of Tissue Engineering, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran. .
Atashi A; Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Shahroud University of Medical Sciences, Shahroud, Iran.
Eslami MM; Department of Hematology, School of Medicine, Tarbiat Modares University (TMU), Tehran, Iran.; Pokaż więcej
Źródło:: BMC research notes [BMC Res Notes] 2023 Jul 03; Vol. 16 (1), pp. 132. Date of Electronic Publication: 2023 Jul 03.
Typ publikacji:: Journal Article
MeSH Terms:: RNA, Circular*/genetics
Breast Neoplasms*/genetics
Neoplastic Stem Cells*
Forkhead Box Protein O3*/genetics
Spheroids, Cellular ; Gene Expression Regulation, Neoplastic ; Cell Line, Tumor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Cuproptosis engages in c-Myc-mediated breast cancer stemness.
Autorzy:: Wang R; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China.
Xu K; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China.
Chen Q; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China.
Hu Q; Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, 226001, China.
Zhang J; Phase I Clinical Trial Center, Fudan University Shanghai Cancer Center, Shanghai, China. .
Guan X; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China. .; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, 211166, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2023 Jun 23; Vol. 21 (1), pp. 409. Date of Electronic Publication: 2023 Jun 23.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Apoptosis*
Proto-Oncogene Proteins c-myc*/genetics
Proto-Oncogene Proteins c-myc*/metabolism
Breast Neoplasms*
Neoplastic Stem Cells*
Copper ; Phenotype ; Humans ; Female

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Frizzled class receptor 5 contributes to ovarian cancer chemoresistance through aldehyde dehydrogenase 1A1.
Autorzy:: Xia Y; Department of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang, Liaoning Province, 110122, P.R. China.
Wang S; Department of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang, Liaoning Province, 110122, P.R. China.
Sun Y; Department of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang, Liaoning Province, 110122, P.R. China.
Wang W; Department of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang, Liaoning Province, 110122, P.R. China.
Chang S; Department of Biomedical Engineer, School of Intelligent Medicine, China Medical University, Shenyang, Liaoning Province, 110122, P.R. China. .
Zhang Z; Department of Pancreatic and Biliary Surgery, The First Hospital of China Medical University, Shenyang, Liaoning Province, 110001, P.R. China. .
Zhao C; Department of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang, Liaoning Province, 110122, P.R. China. .; Pokaż więcej
Źródło:: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Mar 27; Vol. 22 (1), pp. 194. Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:: Journal Article
MeSH Terms:: Aldehyde Dehydrogenase*/genetics
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/metabolism
Humans ; Animals ; Mice ; Female ; Drug Resistance, Neoplasm ; Proto-Oncogene Proteins c-akt/metabolism ; Neoplasm Recurrence, Local/pathology ; Cell Line, Tumor ; Neoplastic Stem Cells/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Chronic hypoxia remodels the tumor microenvironment to support glioma stem cell growth.
Autorzy:: Nicholson JG; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Cirigliano S; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Singhania R; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Haywood C; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Shahidi Dadras M; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Yoshimura M; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Vanderbilt D; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.
Liechty B; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY, USA.
Fine HA; Department of Neurology, Weill Cornell Medicine, New York, NY, USA. .; Pokaż więcej
Źródło:: Acta neuropathologica communications [Acta Neuropathol Commun] 2024 Mar 25; Vol. 12 (1), pp. 46. Date of Electronic Publication: 2024 Mar 25.
Typ publikacji:: Journal Article
MeSH Terms:: Brain Neoplasms*/pathology
Glioma*/pathology
Glioblastoma*/pathology
Humans ; Tumor Microenvironment ; Ligands ; Neoplastic Stem Cells/metabolism ; Hypoxia/metabolism ; Cell Line, Tumor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1/PLK3/HIF1α signaling.
Autorzy:: Luo F; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
Zhang M; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
Sun B; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
Xu C; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
Yang Y; Pediatric Translational Medicine Institute, Department of Hematology & Oncology, Committee Key Laboratory of Pediatric Hematology & Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, National Health Committee Key Laboratory of Pediatric Hematology & Oncology, Shanghai, 200127, China.
Zhang Y; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
Li S; Pediatric Translational Medicine Institute, Department of Hematology & Oncology, Committee Key Laboratory of Pediatric Hematology & Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, National Health Committee Key Laboratory of Pediatric Hematology & Oncology, Shanghai, 200127, China.
Chen G; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
Chen C; Academy of Biomedical Engineering, the Third Affiliated Hospital, Kunming Medical University, Kunming, 650500, China. .
Li Y; Pediatric Translational Medicine Institute, Department of Hematology & Oncology, Committee Key Laboratory of Pediatric Hematology & Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, National Health Committee Key Laboratory of Pediatric Hematology & Oncology, Shanghai, 200127, China. .
Feng H; State Key Laboratory of Systems Medicine for Cancer, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China. .; Pokaż więcej
Źródło:: Molecular cancer [Mol Cancer] 2024 Mar 22; Vol. 23 (1), pp. 60. Date of Electronic Publication: 2024 Mar 22.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/genetics
Triple Negative Breast Neoplasms*/metabolism
Animals ; Humans ; Cell Line, Tumor ; Breast/metabolism ; Signal Transduction ; Paclitaxel/pharmacology ; Disease Models, Animal ; Neoplastic Stem Cells/metabolism ; Histone-Lysine N-Methyltransferase/metabolism ; Polo-like Kinases ; Protein Serine-Threonine Kinases/metabolism ; Tumor Suppressor Proteins/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Development and clinical validation of a seven-gene signature based on tumor stem cell-related genes to predict ovarian cancer prognosis.
Autorzy:: Wang G; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
Liu X; Shenyang Women's and Children's Hospital, Shenyang, China.
You Y; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
Chen S; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
Chang X; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
Yang Q; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China. .; Pokaż więcej
Źródło:: Journal of ovarian research [J Ovarian Res] 2024 Mar 13; Vol. 17 (1), pp. 58. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:: Journal Article
MeSH Terms:: Ovarian Neoplasms*/genetics
Humans ; Female ; Prognosis ; Nomograms ; Neoplastic Stem Cells

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Regulation of cancer stem cells by CXCL1, a chemokine whose secretion is controlled by MCM2.
Autorzy:: Kahm YJ; Department of Radiation Biology, Environmental Safety Assessment Research Division, Korea Atomic Energy Research Institute, 111, Daedeok-Daero 989 Beon-Gil, Yuseong-Gu, 34057, Daejeon, Korea.; Department of Radiation Science and Technology, Korea University of Science and Technology, Yuseong-Gu, 34113, Daejeon, Korea.
Kim IG; Department of Radiation Biology, Environmental Safety Assessment Research Division, Korea Atomic Energy Research Institute, 111, Daedeok-Daero 989 Beon-Gil, Yuseong-Gu, 34057, Daejeon, Korea.; Department of Radiation Science and Technology, Korea University of Science and Technology, Yuseong-Gu, 34113, Daejeon, Korea.
Kim RK; Department of Radiation Biology, Environmental Safety Assessment Research Division, Korea Atomic Energy Research Institute, 111, Daedeok-Daero 989 Beon-Gil, Yuseong-Gu, 34057, Daejeon, Korea. .; Department of Radiation Science and Technology, Korea University of Science and Technology, Yuseong-Gu, 34113, Daejeon, Korea. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Mar 07; Vol. 24 (1), pp. 319. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:: Journal Article
MeSH Terms:: Minichromosome Maintenance Proteins*/genetics
Lung Neoplasms*
Humans ; Chemokine CXCL1 ; Proteins ; Neoplastic Stem Cells/metabolism ; Minichromosome Maintenance Complex Component 2/genetics ; Minichromosome Maintenance Complex Component 2/metabolism ; Cell Cycle Proteins/genetics ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: ThermomiR-377-3p-induced suppression of Cirbp expression is required for effective elimination of cancer cells and cancer stem-like cells by hyperthermia.
Autorzy:: Lin TY; Laboratory Animal Management Center, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.; Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Jia JS; Laboratory Animal Management Center, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.; Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Luo WR; Cancer Research Institute, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen Third People's Hospital, Shenzhen, 518112, China.
Lin XL; Laboratory Animal Management Center, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.; Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510315, China.
Xiao SJ; Department of Pathology, The Second Affiliated Hospital of Guilin Medical University, Guilin, 541199, China.
Yang J; Laboratory Animal Management Center, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.; Department of Imaging, Central Hospital of Shaoyang, Shaoyang, 422000, China.
Xia JW; The Third People's Hospital of Kunming (The Sixth Affiliated Hospital of Dali University), Kunming, 650041, China.
Zhou C; Department of Pathology, The Second Affiliated Hospital of Guilin Medical University, Guilin, 541199, China.
Zhou ZH; Laboratory Animal Management Center, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Lin SJ; Laboratory Animal Management Center, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Li QW; Laboratory Animal Management Center, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Yang ZZ; Laboratory Animal Management Center, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Lei Y; Laboratory Animal Management Center, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Yang WQ; School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, 510515, China.
Shen HF; Laboratory Animal Management Center, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Huang SH; Laboratory Animal Management Center, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Wang SC; Laboratory Animal Management Center, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.; Department of Pathology, School of Basic Medicine, Guangdong Medical University, Dongguan, 523808, China.
Chen LB; School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, 510515, China.
Yang YL; School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, 510515, China.
Xue SW; Laboratory Animal Management Center, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Li YL; Laboratory Animal Management Center, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Dai GQ; Laboratory Animal Management Center, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Zhou Y; Laboratory Animal Management Center, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Li YC; Laboratory Animal Management Center, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Wei F; Laboratory Animal Management Center, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Rong XX; Department of Oncology, Nanfang Hospital, Southern Medical University, Guang‑zhou, 510515, China.
Luo XJ; Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510315, China.
Zhao BX; Laboratory Animal Management Center, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China. .
Huang WH; Guangdong Engineering Research Center for Translation of Medical 3D Printing Application, Guangdong Provincial Key Laboratory of Medical Biomechanics, National Key Discipline of Human Anatomy, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China. .; Guangdong Medical Innovation Platform for Translation of 3D Printing Application, The Third Affiliated Hospital of Southern Medical University, Southern Medical University, Guangzhou, 510000, China. .; Orthopaedic Center, Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Zhanjiang, 524001, China. .
Xiao D; Laboratory Animal Management Center, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China. Xiao_.; Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China. Xiao_.; Guangzhou Southern Medical Laboratory Animal Sci.&Tech. Co.,Ltd, Guangzhou, 510515, China. Xiao_.; National Demonstration Center for Experimental Education of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China. Xiao_.; Department of Stomatology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China. Xiao_.
Sun Y; Laboratory Animal Management Center, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China. .; Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Feb 29; Vol. 43 (1), pp. 62. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:: Journal Article
MeSH Terms:: Nasopharyngeal Neoplasms*/pathology
MicroRNAs*/genetics
Hyperthermia, Induced*
Diterpenes, Kaurane*
Animals ; Humans ; Sincalide/metabolism ; Nasopharyngeal Carcinoma/genetics ; Nasopharyngeal Carcinoma/therapy ; Nasopharyngeal Carcinoma/pathology ; Neoplastic Stem Cells/metabolism ; Cell Line, Tumor ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors.
Autorzy:: Muñoz-Galván S; Instituto de Biomedicina de Sevilla, IBIS, Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Consejo Superior de Investigaciones Científicas, Avda. Manuel Siurot s/n 41013, Seville, Spain. .; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. .
Verdugo-Sivianes EM; Instituto de Biomedicina de Sevilla, IBIS, Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Consejo Superior de Investigaciones Científicas, Avda. Manuel Siurot s/n 41013, Seville, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
Santos-Pereira JM; Centro Andaluz de Biología del Desarrollo (CABD), Consejo Superior de Investigaciones Científicas, Universidad Pablo de Olavide, Seville, 41013, Spain.
Estevez-García P; Instituto de Biomedicina de Sevilla, IBIS, Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Consejo Superior de Investigaciones Científicas, Avda. Manuel Siurot s/n 41013, Seville, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
Carnero A; Instituto de Biomedicina de Sevilla, IBIS, Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Consejo Superior de Investigaciones Científicas, Avda. Manuel Siurot s/n 41013, Seville, Spain. .; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Feb 26; Vol. 43 (1), pp. 57. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:: Journal Article
MeSH Terms:: Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/pathology
Phospholipase D*/genetics
Female ; Humans ; Cell Line, Tumor ; Drug Resistance, Neoplasm/genetics ; Gene Expression Regulation, Neoplastic ; Hypoxia-Inducible Factor 1, alpha Subunit/genetics ; Hypoxia-Inducible Factor 1, alpha Subunit/metabolism ; Neoplastic Stem Cells/metabolism ; Transcription Factors/metabolism ; Tumor Hypoxia ; Animals

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: PARD3 drives tumorigenesis through activating Sonic Hedgehog signalling in tumour-initiating cells in liver cancer.
Autorzy:: Wu J; School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Tan HY; School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.; Centre for Chinese Medicine Drug Development, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China.
Chan YT; School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Lu Y; School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Feng Z; School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Yuan H; School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Zhang C; School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Feng Y; School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Wang N; School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Feb 06; Vol. 43 (1), pp. 42. Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:: Journal Article
MeSH Terms:: Adaptor Proteins, Signal Transducing*/metabolism
Carcinoma, Hepatocellular*/pathology
Cell Cycle Proteins*/metabolism
Liver Neoplasms*/pathology
Humans ; Carcinogenesis/metabolism ; Cell Line, Tumor ; Cell Transformation, Neoplastic/metabolism ; Choline/metabolism ; Hedgehog Proteins/genetics ; Hedgehog Proteins/metabolism ; Neoplastic Stem Cells/metabolism ; RNA, Guide, CRISPR-Cas Systems

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Clinicopathological and prognostic significance of SWI/SNF complex subunits in undifferentiated gastric carcinoma.
Autorzy:: Zhang Z; Weihai Municipal Hospital, Shandong University, Weihai, 264200, Shandong, China.; Department of Oncology, Shouguang People's Hospital, Weifang, 262700, Shandong, China.
Li Q; Department of Pathology, Weihai Municipal Hospital, Shandong University, Weihai, 264200, Shandong, China.
Sun S; Department of Oncology, Weihai Municipal Hospital, Shandong University, Weihai, 264200, Shandong, China.
Li Z; Weifang Medical College, Weifang, 261053, Shandong, China.
Cui ZG; Department of Environmental Health, University of Fukui School of Medical Science, 23-3 Matsuoka Shimoaizuki, Eiheiji, Fukui, 910-1193, Japan.
Zhang M; Department of Pathology, Qinghai Provincial People's Hospital, Xining, 810000, Qinghai, China.
Liu Q; Department of Pathology, Weihai Municipal Hospital, Shandong University, Weihai, 264200, Shandong, China.
Zhang Y; Department of Pathology, Weihai Municipal Hospital, Shandong University, Weihai, 264200, Shandong, China.
Xiong S; Weifang Medical College, Weifang, 261053, Shandong, China.
Zhang S; Department of Pathology, Weihai Municipal Hospital, Shandong University, Weihai, 264200, Shandong, China. .; Pokaż więcej
Źródło:: World journal of surgical oncology [World J Surg Oncol] 2022 Dec 04; Vol. 20 (1), pp. 383. Date of Electronic Publication: 2022 Dec 04.
Typ publikacji:: Journal Article
MeSH Terms:: Neoplastic Stem Cells*/metabolism
Neoplastic Stem Cells*/pathology
Stomach Neoplasms*/genetics
Stomach Neoplasms*/pathology
Stomach Neoplasms*/surgery
Humans ; Carcinoma/genetics ; Carcinoma/pathology ; DNA Helicases ; Nuclear Proteins ; Prognosis ; Sucrose ; Transcription Factors ; Cell Dedifferentiation/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy.
Autorzy:: Alcalá S; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Cancer, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain.; Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Villarino L; Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS), and Departamento de Química Orgánica, Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain.
Ruiz-Cañas L; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Cancer, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain.; Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Couceiro JR; Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS), and Departamento de Química Orgánica, Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain.
Martínez-Calvo M; Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS), and Departamento de Química Orgánica, Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain.
Palencia-Campos A; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Cancer, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain.; Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Navarro D; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Cancer, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain.; Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Cabezas-Sainz P; Department of Zoology, Genetics and Physical Anthropology, Veterinary Faculty, USC, Lugo, Spain.
Rodriguez-Arabaolaza I; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Cancer, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain.; Facultad de Ciencia y Técnología, Universidad del País Vasco, 48940, Leioa (Bizkaia), Spain.
Cordero-Barreal A; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Cancer, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain.; Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Trilla-Fuertes L; Molecular Oncology and Pathology Lab, Instituto de Genética Médica y Molecular-INGEMM, Instituto de Investigación Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.; Biomedica Molecular Medicine SL, Madrid, Spain.
Rubiolo JA; Department of Zoology, Genetics and Physical Anthropology, Veterinary Faculty, USC, Lugo, Spain.
Batres-Ramos S; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Cancer, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain.; Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Vallespinos M; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Cancer, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain.; Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
González-Páramos C; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Cancer, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Madrid, Spain.; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
Rodríguez J; Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS), and Departamento de Química Orgánica, Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain.
Gámez-Pozo A; Molecular Oncology and Pathology Lab, Instituto de Genética Médica y Molecular-INGEMM, Instituto de Investigación Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.; Biomedica Molecular Medicine SL, Madrid, Spain.
Vara JÁF; Molecular Oncology and Pathology Lab, Instituto de Genética Médica y Molecular-INGEMM, Instituto de Investigación Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.; Centro de Investigación Biomédica en Red, Área Cáncer, CIBERONC, ISCIII, Madrid, Spain.
Fernández SF; Servicio de Cirugía Torácica, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Berlinches AB; Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Servicio de Anatomía Patológica, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Moreno-Mata N; Servicio de Cirugía Torácica, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Redondo AMT; Biobanco Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Carrato A; Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Centro de Investigación Biomédica en Red, Área Cáncer, CIBERONC, ISCIII, Madrid, Spain.; Pancreatic Cancer Europe (PCE) Chairperson, Brussels, Belgium.
Hermann PC; Department of Internal Medicine I, Ulm University, Ulm, Germany.
Sánchez L; Department of Zoology, Genetics and Physical Anthropology, Veterinary Faculty, USC, Lugo, Spain.
Torrente S; Valuation, Transfer and Entrepreneurship Area, USC, Santiago de Compostela, Spain.
Fernández-Moreno MÁ; Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Madrid, Spain.; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Rare Diseases, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain.
Mascareñas JL; Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS), and Departamento de Química Orgánica, Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain. .
Sainz B Jr; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Cancer, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain. .; Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain. .; Centro de Investigación Biomédica en Red, Área Cáncer, CIBERONC, ISCIII, Madrid, Spain. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Jan 27; Vol. 43 (1), pp. 33. Date of Electronic Publication: 2024 Jan 27.
Typ publikacji:: Journal Article
MeSH Terms:: Ruthenium*/pharmacology
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/metabolism
Humans ; Oxidative Phosphorylation ; Mitochondria/metabolism ; Neoplastic Stem Cells/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies.
Autorzy:: Ambrosini G; Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, 37134, Verona, Italy.
Cordani M; Department of Biochemistry and Molecular Biology, Faculty of Biology, Complutense University, 28040, Madrid, Spain. .; Instituto de Investigaciones Sanitarias San Carlos (IdISSC), 28040, Madrid, Spain. .
Zarrabi A; Department of Biomedical Engineering, Faculty of Engineering & Natural Sciences, Istinye University, Istanbul, 34396, Turkey.; Department of Research Analytics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, 600 077, India.
Alcon-Rodriguez S; Departamento de Morfología y Biología Celular, School of Medicine, Julián Claveria 6, 33006, Oviedo, Spain.; Instituto Universitario de Oncología del Principado de Asturias (IUOPA), University of Oviedo, 33006, Oviedo, Spain.; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias (HUCA), 33011, Oviedo, Spain.
Sainz RM; Departamento de Morfología y Biología Celular, School of Medicine, Julián Claveria 6, 33006, Oviedo, Spain.; Instituto Universitario de Oncología del Principado de Asturias (IUOPA), University of Oviedo, 33006, Oviedo, Spain.; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias (HUCA), 33011, Oviedo, Spain.
Velasco G; Department of Biochemistry and Molecular Biology, Faculty of Biology, Complutense University, 28040, Madrid, Spain.; Instituto de Investigaciones Sanitarias San Carlos (IdISSC), 28040, Madrid, Spain.
Gonzalez-Menendez P; Departamento de Morfología y Biología Celular, School of Medicine, Julián Claveria 6, 33006, Oviedo, Spain. .; Instituto Universitario de Oncología del Principado de Asturias (IUOPA), University of Oviedo, 33006, Oviedo, Spain. .; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias (HUCA), 33011, Oviedo, Spain. .
Dando I; Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, 37134, Verona, Italy. .; Pokaż więcej
Źródło:: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Jan 12; Vol. 22 (1), pp. 36. Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Prostatic Neoplasms*/genetics
Neoplasms*/pathology
Male ; Humans ; Epigenesis, Genetic ; Tumor Microenvironment ; Mutation ; Neoplastic Stem Cells/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer.
Autorzy:: Li XH; Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfengdong Road, Guangzhou, 510060, China.
Huang GZ; Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfengdong Road, Guangzhou, 510060, China.
Xu ZL; Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfengdong Road, Guangzhou, 510060, China.
Zhao CY; Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Dong XY; Department of Gynecology, Guangdong Hydropower Hospital, Guangzhou, 510060, China.
Cui BK; Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfengdong Road, Guangzhou, 510060, China.
Lin XJ; Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfengdong Road, Guangzhou, 510060, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2023 Dec 14; Vol. 21 (1), pp. 911. Date of Electronic Publication: 2023 Dec 14.
Typ publikacji:: Journal Article
MeSH Terms:: Drug Resistance, Neoplasm*
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/metabolism
Humans ; Cell Line, Tumor ; Signal Transduction ; Prognosis ; Neoplastic Stem Cells/pathology ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: The application of nanoparticles in theranostic systems targeting breast cancer stem cells: current progress and future challenges.
Autorzy:: Lin X; Oncology Institute, Affiliated Hospital of Jiangnan University, Wuxi, 214062, Jiangsu, China.
Wang Y; Oncology Institute, Affiliated Hospital of Jiangnan University, Wuxi, 214062, Jiangsu, China.
Fang K; Oncology Institute, Affiliated Hospital of Jiangnan University, Wuxi, 214062, Jiangsu, China.
Guo Z; Department of Oncological Surgery, Affiliated Hospital of Jiangnan University, Wuxi, 214062, Jiangsu, China.
Lin N; Qilu Hospital of Shandong University, Shandong, 250000, China.
Li L; Oncology Institute, Affiliated Hospital of Jiangnan University, Wuxi, 214062, Jiangsu, China. .; Pokaż więcej
Źródło:: Stem cell research & therapy [Stem Cell Res Ther] 2023 Dec 10; Vol. 14 (1), pp. 356. Date of Electronic Publication: 2023 Dec 10.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Breast Neoplasms*/drug therapy
Antineoplastic Agents*/pharmacology
Nanoparticles*
Female ; Humans ; Precision Medicine ; Neoplastic Stem Cells/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 21.

Tytuł:: Significant CircRNAs in liver cancer stem cell exosomes: mediator of malignant propagation in liver cancer?
Autorzy:: Han T; Department of Medical Oncology, the First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, Liaoning Province, 110001, China.
Chen L; Department of Medical Oncology, the First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, Liaoning Province, 110001, China.; Postgraduate College, China Medical University, 77 Puhe Road, North New District, Shenyang, Liaoning Province, 110122, China.; Department of Medical Oncology, General Hospital of Northern Theater Command, 83 Wenhua Road, Shenhe District, Shenyang, Liaoning Province, 110017, China.
Li K; Department of Medical Oncology, the First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, Liaoning Province, 110001, China.
Hu Q; Department of Medical Oncology, the First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, Liaoning Province, 110001, China.
Zhang Y; Department of Oncology, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, No. 358 Datong Road, Pudong New Area, Shanghai, 200137, China.
You X; Postgraduate College, China Medical University, 77 Puhe Road, North New District, Shenyang, Liaoning Province, 110122, China.
Han L; Department of Hepatobiliary Surgery, General Hospital of Northern Theater Command, 83 Wenhua Road, Shenhe District, Shenyang, Liaoning Province, 110017, China.
Chen T; Department of Oncology, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, No. 358 Datong Road, Pudong New Area, Shanghai, 200137, China. .
Li K; Department of Gastrointestinal Oncology Surgery, the First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, Liaoning Province, 110001, China. .; Pokaż więcej
Źródło:: Molecular cancer [Mol Cancer] 2023 Dec 05; Vol. 22 (1), pp. 197. Date of Electronic Publication: 2023 Dec 05.
Typ publikacji:: Letter; Research Support, Non-U.S. Gov't
MeSH Terms:: Liver Neoplasms*/pathology
Carcinoma, Hepatocellular*/pathology
Exosomes*/genetics
Exosomes*/pathology
MicroRNAs*
Humans ; RNA, Circular/genetics ; Cell Line, Tumor ; Neoplastic Stem Cells/pathology

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 22.

Tytuł:: Overcoming BCR::ABL1 dependent and independent survival mechanisms in chronic myeloid leukaemia using a multi-kinase targeting approach.
Autorzy:: Busch C; Paul O'Gorman Leukaemia Research Centre, School of Cancer Sciences, University of Glasgow, Glasgow, G12 0ZD, UK.
Mulholland T; Centre for Microsystems and Photonics, Electronic and Electrical Engineering, University of Strathclyde, Glasgow, G1 1XW, UK.
Zagnoni M; Centre for Microsystems and Photonics, Electronic and Electrical Engineering, University of Strathclyde, Glasgow, G1 1XW, UK.
Dalby M; Mazumdar-Shaw Advanced Research Centre, School of Molecular Biosciences, University of Glasgow, Glasgow, G11 6EW, UK.
Berry C; Mazumdar-Shaw Advanced Research Centre, School of Molecular Biosciences, University of Glasgow, Glasgow, G11 6EW, UK.
Wheadon H; Paul O'Gorman Leukaemia Research Centre, School of Cancer Sciences, University of Glasgow, Glasgow, G12 0ZD, UK. .; Pokaż więcej
Źródło:: Cell communication and signaling : CCS [Cell Commun Signal] 2023 Nov 29; Vol. 21 (1), pp. 342. Date of Electronic Publication: 2023 Nov 29.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy
Humans ; Imatinib Mesylate/pharmacology ; Imatinib Mesylate/therapeutic use ; Bone Marrow/metabolism ; Signal Transduction ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Apoptosis ; Receptor Protein-Tyrosine Kinases/metabolism ; Fusion Proteins, bcr-abl ; Neoplastic Stem Cells/metabolism ; Drug Resistance, Neoplasm

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 23.

Tytuł:: Oxidative stress regulation and related metabolic pathways in epithelial-mesenchymal transition of breast cancer stem cells.
Autorzy:: Farahzadi R; Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Valipour B; Department of Anatomical Sciences, Sarab Faculty of Medical Sciences, Sarab, Iran.
Fathi E; Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.
Pirmoradi S; Cellular and Molecular Research Center, Cellular and Molecular Medicine Research Institute, Urmia University of Medical Sciences, Urmia, Iran.
Molavi O; Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.; Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Montazersaheb S; Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. .
Sanaat Z; Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. .; Pokaż więcej
Źródło:: Stem cell research & therapy [Stem Cell Res Ther] 2023 Nov 28; Vol. 14 (1), pp. 342. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Epithelial-Mesenchymal Transition*
Breast Neoplasms*/pathology
Humans ; Female ; Transcription Factors/genetics ; Transcription Factors/metabolism ; Oxidative Stress ; Neoplastic Stem Cells/metabolism ; Snail Family Transcription Factors/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 24.

Tytuł:: Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity.
Autorzy:: Zheng Q; Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.; State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Tang J; Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.; State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Aicher A; Precision Immunotherapy, Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.; Immunology Research and Development Center, China Medical University, Taichung, Taiwan.
Bou Kheir T; Barts Cancer Institute, Queen Mary University of London, London, UK.
Sabanovic B; Pancreatic Cancer Heterogeneity Lab, Candiolo Cancer Institute - FPO - IRCCS, Candiolo, Turin, Italy.
Ananthanarayanan P; Pancreatic Cancer Heterogeneity Lab, Candiolo Cancer Institute - FPO - IRCCS, Candiolo, Turin, Italy.
Reina C; Pancreatic Cancer Heterogeneity Lab, Candiolo Cancer Institute - FPO - IRCCS, Candiolo, Turin, Italy.
Chen M; Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.; State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Gu JM; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
He B; National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, China.
Alcala S; Molecular Pathology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Instituto de Investigaciones Biomédicas 'Alberto Sols' CSIC-UAM, Chronic Diseases and Cancer Area 3 Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Centro de Investigación Biomédica en Red, Área Cáncer, CIBERONC, ISCIII, Madrid, Spain.
Behrens D; Experimental Pharmacology and Oncology Berlin-Buch GmbH, Berlin, Germany.
Lawlo RT; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Verona, Italy.; ARC-Net, Applied Research On Cancer Centre, University of Verona, Verona, Italy.
Scarpa A; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Verona, Italy.; ARC-Net, Applied Research On Cancer Centre, University of Verona, Verona, Italy.
Hidalgo M; Clinical Research Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Sainz B Jr; Molecular Pathology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Instituto de Investigaciones Biomédicas 'Alberto Sols' CSIC-UAM, Chronic Diseases and Cancer Area 3 Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Centro de Investigación Biomédica en Red, Área Cáncer, CIBERONC, ISCIII, Madrid, Spain.
Sancho P; IIS Aragon, Hospital Universitario Miguel Servet, 50009, Saragossa, Spain. .
Heeschen C; Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. .; State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .; Pancreatic Cancer Heterogeneity Lab, Candiolo Cancer Institute - FPO - IRCCS, Candiolo, Turin, Italy. .; Molecular Pathology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Nov 28; Vol. 42 (1), pp. 323. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:: Journal Article
MeSH Terms:: Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/metabolism
Carcinoma, Pancreatic Ductal*/drug therapy
Carcinoma, Pancreatic Ductal*/genetics
Carcinoma, Pancreatic Ductal*/metabolism
Humans ; Animals ; Mice ; Signal Transduction ; Proto-Oncogene Proteins c-myc/genetics ; Proto-Oncogene Proteins c-myc/metabolism ; Cell Line, Tumor ; Neoplasm Recurrence, Local/pathology ; Neoplastic Stem Cells/metabolism ; Receptors, Cytoplasmic and Nuclear/metabolism ; SOXB1 Transcription Factors/genetics ; SOXB1 Transcription Factors/metabolism ; Pancreatic Neoplasms
SCR Disease Name:: Spinocerebellar Ataxia, Autosomal Recessive 2

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 25.

Tytuł:: The promoting effect and mechanism of MAD2L2 on stemness maintenance and malignant progression in glioma.
Autorzy:: Liu Z; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210000, China.
Wang S; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210000, China.; Putuo People's Hospital, Tongji University, Shanghai, 200060, China.
Yu K; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210000, China.
Chen K; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210000, China.
Zhao L; Department of Neurosurgery, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, 210000, China.
Zhang J; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210000, China.
Dai K; Department of Neurosugery, Emergency General Hospital, Beijing, 100028, China.
Zhao P; Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210000, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2023 Nov 28; Vol. 21 (1), pp. 863. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Glioblastoma*/pathology
Brain Neoplasms*/pathology
Glioma*/pathology
Animals ; Humans ; Cell Proliferation ; Neoplastic Stem Cells/pathology ; Disease Models, Animal ; Luciferases/metabolism ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic ; Mad2 Proteins/genetics ; Mad2 Proteins/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Neoplastic Stem Cells"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Publikacja

Język